161
Views
7
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients

&
Pages 11-14 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eric Senneville & Sophie Nguyen. (2013) Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn. Expert Opinion on Pharmacotherapy 14:6, pages 723-734.
Read now

Articles from other publishers (6)

Brian M. Hoff, Jenana H. Maker, William E. Dager & Brett H. Heintz. (2019) Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update. Annals of Pharmacotherapy 54:1, pages 43-55.
Crossref
Molly Haselden, Molly Leach & Nicole Bohm. (2013) Daptomycin Dosing Strategies in Patients Receiving Thrice-Weekly Intermittent Hemodialysis. Annals of Pharmacotherapy 47:10, pages 1342-1347.
Crossref
J.T. Kielstein & F. Keller. (2012) Pharmakotherapie bei Patienten mit chronischer NierenkrankheitPharmacotherapy in patients suffering from chronic kidney disease. Der Internist 53:7, pages 802-809.
Crossref
Ennio Polilli, Tamara Ursini, Elena Mazzotta, Federica Sozio, Vincenzo Savini, Domenico D'Antonio, Michelino Barbato, Augusta Consorte & Giustino Parruti. (2012) Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease. Annals of Clinical Microbiology and Antimicrobials 11:1.
Crossref
Christopher W. McIntyre, Susan Shaw & Mohamed T. Eldehni. 2012. Brenner and Rector's The Kidney. Brenner and Rector's The Kidney 2258 2291 .
Ian M. Gould, Roberto Cauda, Silvano Esposito, Francesco Gudiol, Teresita Mazzei & Javier Garau. (2011) Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?. International Journal of Antimicrobial Agents 37:3, pages 202-209.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.